Status:
UNKNOWN
European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Lead Sponsor:
European Society of Cutaneous Lupus Erythematosus e.V.
Conditions:
Lupus Erythematosus, Cutaneous
Lupus Erythematosus, Systemic
Eligibility:
All Genders
18+ years
Brief Summary
Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical manifestations and a variable prognosis. The aim of the study is to create a standardized evaluation of the different ...
Detailed Description
Methods: A core set questionnaire has been developed in the course of the "European Society of Cutaneous Lupus Erythematosus (EUSCLE)", and a total of 40 patients (32 females, 8 males) in two centres,...
Eligibility Criteria
Inclusion
- systemic or cutaneous lupus erythematosus confirmed by histological analysis
- written informed consent available prior to any study-procedures
Exclusion
- patients with conditions that are contrary to the above mentioned criteria
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00420121
Start Date
January 1 2007
End Date
December 1 2019
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Muenster, Department of Dermatology
Münster, North Rhine-Westphalia, Germany, 48149